tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Marc Goodman - 233 which are a Buy (71.47%), 88 which are a Hold (26.99%), 5 which are a Sell (1.53%)
Analyst Marc Goodman works at LEERINK and is covering the Healthcare sector with 676 price targets and ratings displayed on 42 stocks. Previously, Marc Goodman worked at UBS.
Marc Goodman's average stock forecast success ratio is 61.85% with an average time for price targets to be met of 250.98 days.
Most recent stock forecast was given on NBIX, Neurocrine Biosciences at 24-Jul-2023.
Analyst best performing recommendations are on SAGE (SAGE THERAPEUTICS).
The best stock recommendation documented was for SAGE (SAGE THERAPEUTICS) at 12/4/2019. The price target of $63 was fulfilled within 1 day with a profit of $86.21 (57.78%) receiving and performance score of 577.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
170
$16.87 (11.02%)
163
2 months ago
33/34 (97.06%)
$24.97 (28.96%)
433
Buy
182
$28.87 (18.85%)
181
2 months 17 days ago
6/15 (40%)
$28.98 (32.96%)
467
Buy
155
5 months 23 days ago
1/1 (100%)
$21 (15.67%)
90
Buy
172
$18.87 (12.32%)
166
6 months 27 days ago
23/24 (95.83%)
$22.65 (31.91%)
519
Hold
127
7 months 6 days ago
1/1 (100%)
$21.13 (19.96%)
240
Which stock is Marc Goodman is most bullish on?
Which stock is Marc Goodman is most reserved on?
What Year was the first public recommendation made by Marc Goodman?
